Peri-operative Therapy in Thoracic Cancer

The course presents a review of recent changes in the management of resected NSCLC as well as the management of patients with early stage NSCLC treated with SBRT. The four main topics are:

  • Neo-adjuvant and adjuvant immunotherapy
  • Adjuvant Targeted therapy
  • Post-operative Radiotherapy
  • Lung SBRT Distinguishing Progression vs Radiation Fibrosis

Additionally, there is an extra video session on Screening and How Imaging/Staging Availability Affects Survival. It covers the indications, and pitfalls associated with lung cancer screening.

This activity is available from January 31, 2022, through 11:59 p.m. Eastern time on January 30, 2025.

This activity was originally recorded at ASTRO’s Multidisciplinary Thoracic Cancers Symposium, December 2-4th.

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, surgeons, nurses, diagnostic radiologists and medical oncologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss adjuvant targeted therapies and immunotherapy.
  • Explain the role of post-operative radiation therapy.
  • Describe patient management after completion of SBRT.
  • Describe the current recommendations for lung cancer screening.

 

Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
Course opens: 
01/31/2022
Course expires: 
01/30/2025
Cost:
$30.00
Rating: 
0

Moderator: Thomas Stinchcombe, MD, Duke Cancer Center, Durham, North Carolina
Speakers:

  • Catherine Shu, MD, Columbia University, New York and received compensation from AstraZeneca, Genentech, Janssen, Mirati.
  • ​Thomas Stinchcombe, MD, Duke Cancer Center, Durham, North Carolina and receives compensation from Takeda, AstraZeneca, Genentech/Roche, Foundation Medicine, Pfizer, EMD Serono, Novartis, Daiichi Sankyo, Lilly, Medtronic, Puma Biotechnology, Janssen Oncology, Regeneron, Advaxis.
  • ​Pamela Samson, MD, MPHS, Washington University School of Medicine, St. Louis and has nothing to disclose.
  • ​Jeremy Brownstein, MD, MS, The Ohio State University, Columbus, Ohio and has nothing to disclose.
  • Douglas Arenberg, MD, University of Michigan, Ann Arbor, Michigan and has nothing to disclose.

The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.

Disclosure link: 
ASTRO Education Committee

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.

Price

Cost:
$30.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

  • Nonmember: $30
  • Member: $25

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until January 30, 2025, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.